Study Aimed at Identifying Diabetes Triggers
Posted on: Monday, 6 December 2004, 15:00 CST
SEATTLE - Perhaps it's certain foods they eat or the milk they drink. Maybe an intestinal virus sets off the disease. Even stress from family dynamics is a suspect.
No one knows what sets off type 1 diabetes in a child genetically at risk for the disease. No one knows why only one in 30 children with a genetic risk actually develops diabetes, which can cause a host of complications and typically shortens lives.
Scientists at the Pacific Northwest Research Institute in Seattle soon will begin trying to identify "triggers" that send young people on the often-devastating course of diabetes.
In the largest study ever of environmental influences on juvenile diabetes, the Seattle researchers will join scientists at five medical centers worldwide to follow 8,000 youths at high risk for the disease for 15 years.
"We hope to identify at least a few, and hopefully as many as a dozen, exposures (triggers) that are avoidable," said Dr. Bill Hagopian, principal scientist at PNRI and director of the Seattle portion of the research.
By learning about the triggers, the scientists hope to better predict the disease, prevent or delay it and develop better treatments.
The research is being financed by a $35 million grant from the National Institute of Digestive and Diabetes and Kidney Diseases. PNRI will receive about $1 million a year for the project, called TEDDY, for The Environmental Determinants of Diabetes in the Young. Medical centers in Florida, Georgia, Colorado, Germany, Finland and Sweden also will participate.
Starting this week, the Seattle researchers began asking the parents of area newborns if they could test blood left over from nine disease tests already required by the state at birth. They will screen some 44,000 infants to identify 1,200 babies with a certain genetic marker, HLA-DQ, that puts them at risk for diabetes. Then they will closely monitor the children into their teens, looking for possible triggers.
More than 1 million people nationwide are living with type 1 diabetes. The disease occurs when the body's immune system attacks the cells that produce insulin, needed to regulate sugar levels.
Over time, diabetes can damage the eyes, heart, kidneys, nervous system and skin, and most people have shortened life spans. Type 2, the most common form of diabetes, usually is diagnosed in adulthood. About $132 billion a year is spent in the United States on treatment and other costs for all forms of the disease, according to the Centers for Disease Control and Prevention.
In the TEDDY study, researchers will regularly collect blood and stool samples from the children at risk for the disease. They also will analyze toenail samples from the kids and tap water from the families' homes. Families will provide detailed records, including vaccinations, the presence of pets, possible exposure to pesticides and when the child first consumes certain foods such as cow's milk, infant formula and wheat products. They also will provide information about family dynamics.
Source: Advocate; Baton Rouge, La.
Related Articles
- Higher Levels Of A Certain Protein Linked With Lower Risk Of Type 2 Diabetes
- Sanford Children's Health Research Center to Be Dedicated in La Jolla
- Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease
- Children Can Be Cured of Sickle Cell Disease and Thalassemia After Sibling Cord Blood Transplantation: Results From ViaCell and Children's Hospital & Research Center Oakland
- ACTOS(R) (Pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients With Type 2 Diabetes
- Research Team Identifies New Alzheimer's Gene
- Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes Was 7.8% at 30 Years After Diagnosis/COMMENTARY
- Children's Medical Research Institute, Chickasaws Create Diabetes Research Chair
- Children's Medical Research Institute Appoints A. Gardner to Endowed Chair in Pediatric Diabetes
- The CARDS Investigators: Primary Prevention of Cardiovascular Disease With Atorvastatin in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre Randomised Placebo- Controlled Trial
User Comments (0)

RSS Feeds